#United States #Alveo Technologies #Alameda, California #Poultry Medicine #Bird Flu Test

Alveo Technologies' New Breakthrough in Poultry Diagnostics

Alveo Technologies, Inc. has recently made a significant leap in poultry health diagnostics with its pioneering Alveo Sense™ Poultry Avian Influenza Test. This innovative testing solution has been rigorously evaluated by the Poultry Research and Diagnostic Center (PDRC), a recognized leader in poultry medicine, showcasing its capability to accurately identify the H5N1 virus during the acute infection stages in both chickens and ducks. This vital research underscores the growing importance of rapid and precise diagnostic measures in the face of avian flu threats.

Key Findings from the Research

The study, presented at the upcoming 15th International Seminar on Poultry Pathology and Production, confirmed that the Alveo Sense test achieved over 99% accuracy in identifying critical viral targets, including high and low pathogenic strains of H5N1. Conducted in two phases, the research involved monitoring infected ducks over five days and subjected pooled cloacal swabs to careful analysis. The results were striking, demonstrating the test’s reliability even when viral loads were at their lowest.

Dr. Daniel Perez of the PDRC emphasized the urgency of implementing enhanced bio-surveillance tools. “In today’s climate, where the risks associated with bird flu are escalating, rapid diagnostic solutions are crucial. The Alveo Sense test not only produces sensitive results but also supports quick decision-making to tackle potential outbreaks effectively,” he stated.

Advancing Poultry Health

The Alveo Sense test represents a game-changing advancement in poultry diagnostics, offering portable testing capabilities that can be deployed right at the Point of Need™ — whether on a farm or in the field. This application of molecular diagnostics is enabled through IntelliSense™, a patented method that facilitates fast, accurate, and affordable results. As a fully self-contained kit, it equips poultry producers with the tools necessary to respond to viral threats immediately, without the need for central laboratory analysis.

The system includes a mobile app that generates results within 45 minutes, allowing swift action to mitigate any identified risks. Importantly, the data generated can be seamlessly uploaded to the Alveo Vista™ portal for secure cloud storage, providing stakeholders with actionable insights to enhance biosecurity measures.

The Future of Poultry Diagnostics

As avian influenza continues to pose significant risks to the poultry industry worldwide, Alveo Technologies is committed to reshaping the landscape of diagnostics. The ongoing collaboration with PDRC and the application of this cutting-edge technology offer promising paths for achieving healthier, more sustainable poultry production.

The efficacy of the Alveo Sense test opens the door to increased participation of regulatory agencies and veterinarians in fostering an environment of sound health practices among poultry producers. With tools designed for rapid detection and response based on the latest molecular science, Alveo is poised to lead the charge against evolving threats to animal health and food security.

In Dr. Perez’s words, “By implementing such cutting-edge solutions, we can significantly impact avian health management and ensure the safety of our food supply chain.” With innovations like the Alveo Sense test, the poultry industry may now navigate the complexities of avian influenza with heightened confidence and effectiveness.

To learn more about Alveo Technologies and explore their transformative diagnostics, visit alveotechnologies.com or follow them on LinkedIn for ongoing updates.